176 related articles for article (PubMed ID: 24750227)
1. Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by (18) F DOPA-PET/CT scanning.
Kühnen P; Matthae R; Arya V; Hauptmann K; Rothe K; Wächter S; Singer M; Mohnike W; Eberhard T; Raile K; Lauffer LM; Iakoubov R; Hussain K; Blankenstein O
Clin Endocrinol (Oxf); 2014 Dec; 81(6):847-54. PubMed ID: 24750227
[TBL] [Abstract][Full Text] [Related]
2. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.
Meintjes M; Endozo R; Dickson J; Erlandsson K; Hussain K; Townsend C; Menezes L; Bomanji J
Nucl Med Commun; 2013 Jun; 34(6):601-8. PubMed ID: 23571817
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
[TBL] [Abstract][Full Text] [Related]
4. The role of
Chroustova D; Trnka J; Pudlac A; Obermannova B; Lambert L
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):279-283. PubMed ID: 32448747
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of 23 Chinese children with congenital hyperinsulinism undergoing pancreatectomy.
Zhang L; Xu ZD; Liu M; Zeng Q; Li RM; Wang JY; Wang HM; Li L; Qin H; Yan J; Wu YJ; Zhu C; Ni GC; Sang YM
Endokrynol Pol; 2021; 72(5):584-585. PubMed ID: 34292572
[TBL] [Abstract][Full Text] [Related]
6. 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation.
Christiansen CD; Petersen H; Nielsen AL; Detlefsen S; Brusgaard K; Rasmussen L; Melikyan M; Ekström K; Globa E; Rasmussen AH; Hovendal C; Christesen HT
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):250-261. PubMed ID: 29116340
[TBL] [Abstract][Full Text] [Related]
7. 18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism.
Yang J; Yuan L; Meeks JK; Zhang N; Li C; Hao R
J Pediatr Endocrinol Metab; 2012; 25(7-8):619-22. PubMed ID: 23155683
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.
Barthlen W; Blankenstein O; Mau H; Koch M; Höhne C; Mohnike W; Eberhard T; Fuechtner F; Lorenz-Depiereux B; Mohnike K
J Clin Endocrinol Metab; 2008 Mar; 93(3):869-75. PubMed ID: 18073294
[TBL] [Abstract][Full Text] [Related]
9. [Feasibility of domestic (18)F-DOPA PET/CT scanning in the differential diagnosis of pancreatic lesions in children with hyperinsulinemic hypoglycemia].
Zhang MY; Ge JJ; Pei Z; Dong KR; Chen L; Wang X; Zhang ZW; Li XJ; Xi L; Cheng RQ; Lu GP; Guan YH; Luo FH
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):785-789. PubMed ID: 29050119
[No Abstract] [Full Text] [Related]
10. Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.
Masue M; Nishibori H; Fukuyama S; Yoshizawa A; Okamoto S; Doi R; Uemoto S; Tokumi T; Kasai T; Yorifuji T
Clin Endocrinol (Oxf); 2011 Sep; 75(3):342-6. PubMed ID: 21521340
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis.
Treglia G; Mirk P; Giordano A; Rufini V
Pediatr Radiol; 2012 Nov; 42(11):1372-9. PubMed ID: 22885604
[TBL] [Abstract][Full Text] [Related]
12. Rapid genetic analysis, imaging with 18F-DOPA-PET/CT scan and laparoscopic surgery in congenital hyperinsulinism.
Cherubini V; Bagalini LS; Ianilli A; Marigliano M; Biagioni M; Carnielli V; Iasonni V; Berbellini A; Hussain K; Gabrielli O
J Pediatr Endocrinol Metab; 2010; 23(1-2):171-7. PubMed ID: 20432820
[TBL] [Abstract][Full Text] [Related]
13. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.
Ribeiro MJ; Boddaert N; Bellanné-Chantelot C; Bourgeois S; Valayannopoulos V; Delzescaux T; Jaubert F; Nihoul-Fékété C; Brunelle F; De Lonlay P
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2120-8. PubMed ID: 17661030
[TBL] [Abstract][Full Text] [Related]
14. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.
Capito C; Khen-Dunlop N; Ribeiro MJ; Brunelle F; Aigrain Y; Crétolle C; Jaubert F; De Lonlay P; Nihoul-Fékété C
Radiology; 2009 Oct; 253(1):216-22. PubMed ID: 19709999
[TBL] [Abstract][Full Text] [Related]
15. Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning.
Ni J; Ge J; Zhang M; Hussain K; Guan Y; Cheng R; Xi L; Zheng Z; Ren S; Luo F
Eur J Pediatr; 2019 Aug; 178(8):1161-1169. PubMed ID: 31218401
[TBL] [Abstract][Full Text] [Related]
16. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
Kauhanen S; Seppänen M; Minn H; Gullichsen R; Salonen A; Alanen K; Parkkola R; Solin O; Bergman J; Sane T; Salmi J; Välimäki M; Nuutila P
J Clin Endocrinol Metab; 2007 Apr; 92(4):1237-44. PubMed ID: 17227804
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of medically-refractory hyperinsulinism.
Zobel MJ; McFarland C; Ferrera-Cook CT; Padilla BE
Am J Surg; 2020 Jun; 219(6):947-951. PubMed ID: 31757439
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Hardy OT; Hernandez-Pampaloni M; Saffer JR; Scheuermann JS; Ernst LM; Freifelder R; Zhuang H; MacMullen C; Becker S; Adzick NS; Divgi C; Alavi A; Stanley CA
J Clin Endocrinol Metab; 2007 Dec; 92(12):4706-11. PubMed ID: 17895314
[TBL] [Abstract][Full Text] [Related]
19. Lasting 18F-DOPA PET uptake after clinical remission of the focal form of congenital hyperinsulinism.
Yorifuji T; Hosokawa Y; Fujimaru R; Kawakita R; Doi H; Matsumoto T; Nishibori H; Masue M
Horm Res Paediatr; 2011; 76(4):286-90. PubMed ID: 21912073
[TBL] [Abstract][Full Text] [Related]
20. The heterogeneity of focal forms of congenital hyperinsulinism.
Ismail D; Kapoor RR; Smith VV; Ashworth M; Blankenstein O; Pierro A; Flanagan SE; Ellard S; Hussain K
J Clin Endocrinol Metab; 2012 Jan; 97(1):E94-9. PubMed ID: 22031516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
